Verelan® PM Extended-Release Capsules, 300 mg

DRUG3 trials

Sponsors

Mylan Pharmaceuticals Inc

Conditions

Healthy

Phase 1

Fasting Study of Verapamil HCl Extended-Release Capsules 300 mg to Verelan® PM Extended-Release Capsules 300 mg

CompletedNCT00648050

Mylan Pharmaceuticals IncHealthy

Start: 2006-03-31End: 2006-03-31Updated: 2024-04-24

Food Study of Verapamil HCl Extended-Release Capsules 300 mg and Verelan® PM Extended-Release Capsules 300 mg

CompletedNCT00648401

Mylan Pharmaceuticals IncHealthy

Start: 2006-01-31End: 2006-02-28Updated: 2024-04-24

Fasting Applesauce Study of Verapamil HCl Extended-Release Capsules 300 mg and Verelan® PM Extended-Release Capsules 300 mg

CompletedNCT00649805

Mylan Pharmaceuticals IncHealthy

Start: 2006-01-31End: 2006-02-28Updated: 2024-04-24